Nordwand Advisors »

Pmv Pharmaceuticals shares owned by Nordwand Advisors

Quarter-by-quarter ownership of Pmv Pharmaceuticals (PMVP) shares owned by Nordwand Advisors from 13F filings

Historical chart of Nordwand Advisors investment in Pmv Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Pmv Pharmaceuticals held by Nordwand Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pmv Pharmaceuticals by Nordwand Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $3.0k 2.0k 1.49
2024-06-30 $3.2k 2.0k 1.62

More positions owned by Nordwand Advisors

Berkshire Hathaway Inc Del Cl A (BRK.A)
Johnson & Johnson (JNJ)
Novocure Ord Shs (NVCR)
Microsoft Corporation (MSFT)
J P Morgan Exchange Traded F Income Etf (JPIE)
Grab Holdings Class A Ord (GRAB)
Harbor Etf Trust Internatnal Comp (OSEA)
Ardagh Metal Packaging S A SHS (AMBP)
Apple (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
J P Morgan Exchange Traded F Equity Premium (JEPI)
Mp Materials Corp Com Cl A (MP)
Oaktree Specialty Lending Corp (OCSL)
Series Portfolios Tr Panagram Bbb B (CLOZ)
Ishares Tr S&p 500 Val Etf (IVE)

View all positions for Nordwand Advisors

Top funds holding Pmv Pharmaceuticals

OrbiMed Advisors
Arrowpoint Asset Management
Sio Capital Management
Euclidean Capital
Alkeon Capital Management
Vanguard Group
Acadian Asset Management
Partner Fund Management
BML Capital Management
BlackRock
Citadel Advisors
D. E. Shaw & Co
Two Sigma Advisers
Jacobs Levy Equity Management
Personal Cfo Solutions

View all funds holding Pmv Pharmaceuticals